3 Artificial Intelligence (AI) Stocks to Buy Hand Over Fist in February

Procter & Gamble and Clorox offer reliable, well-covered dividends backed by strong fundamentals and long operating histories. PG faces near-term headwinds from high-interest rates and value-seeking consumers, but cost-saving initiatives and a solid balance sheet support continued dividend growth. CLX, despite recent declines in revenue and EPS, maintains a sustainable 4.5% yield and expects margin expansion and price appreciation as macro headwinds ease.

Pfizer has made the investments needed to get its drug pipeline back on track. United Parcel Service’s turnaround effort is starting to show progress.

Quantum computing is entering a more consequential phase as the industry moves toward 2026.